rs748145117

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The NM_000939.4(POMC):​c.250T>G​(p.Trp84Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00000258 in 1,552,500 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

POMC
NM_000939.4 missense

Scores

7
10
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 3.91

Publications

6 publications found
Variant links:
Genes affected
POMC (HGNC:9201): (proopiomelanocortin) This gene encodes a preproprotein that undergoes extensive, tissue-specific, post-translational processing via cleavage by subtilisin-like enzymes known as prohormone convertases. There are eight potential cleavage sites within the preproprotein and, depending on tissue type and the available convertases, processing may yield as many as ten biologically active peptides involved in diverse cellular functions. The encoded protein is synthesized mainly in corticotroph cells of the anterior pituitary where four cleavage sites are used; adrenocorticotrophin, essential for normal steroidogenesis and the maintenance of normal adrenal weight, and lipotropin beta are the major end products. In other tissues, including the hypothalamus, placenta, and epithelium, all cleavage sites may be used, giving rise to peptides with roles in pain and energy homeostasis, melanocyte stimulation, and immune modulation. These include several distinct melanotropins, lipotropins, and endorphins that are contained within the adrenocorticotrophin and beta-lipotropin peptides. The antimicrobial melanotropin alpha peptide exhibits antibacterial and antifungal activity. Mutations in this gene have been associated with early onset obesity, adrenal insufficiency, and red hair pigmentation. Alternatively spliced transcript variants encoding the same protein have been described. [provided by RefSeq, Jan 2016]
POMC Gene-Disease associations (from GenCC):
  • obesity due to pro-opiomelanocortin deficiency
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, Ambry Genetics
  • inherited obesity
    Inheritance: SD, AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.844

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
POMCNM_000939.4 linkc.250T>G p.Trp84Gly missense_variant Exon 3 of 3 ENST00000395826.7 NP_000930.1 P01189
POMCNM_001035256.3 linkc.250T>G p.Trp84Gly missense_variant Exon 4 of 4 NP_001030333.1 P01189
POMCNM_001319204.2 linkc.250T>G p.Trp84Gly missense_variant Exon 4 of 4 NP_001306133.1 P01189
POMCNM_001319205.2 linkc.250T>G p.Trp84Gly missense_variant Exon 3 of 3 NP_001306134.1 P01189

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POMCENST00000395826.7 linkc.250T>G p.Trp84Gly missense_variant Exon 3 of 3 2 NM_000939.4 ENSP00000379170.2 P01189

Frequencies

GnomAD3 genomes
AF:
0.00000660
AC:
1
AN:
151490
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000657
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000199
AC:
3
AN:
150928
AF XY:
0.0000123
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000402
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000354
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000214
AC:
3
AN:
1401010
Hom.:
0
Cov.:
33
AF XY:
0.00000289
AC XY:
2
AN XY:
691554
show subpopulations
African (AFR)
AF:
0.0000634
AC:
2
AN:
31550
American (AMR)
AF:
0.00
AC:
0
AN:
35984
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25172
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35876
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79566
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48250
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5690
European-Non Finnish (NFE)
AF:
9.25e-7
AC:
1
AN:
1080888
Other (OTH)
AF:
0.00
AC:
0
AN:
58034
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.00000660
AC:
1
AN:
151490
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
73992
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40934
American (AMR)
AF:
0.0000657
AC:
1
AN:
15232
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4810
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
302
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67980
Other (OTH)
AF:
0.00
AC:
0
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000506
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 27, 2016
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Dec 17, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.250T>G (p.W84G) alteration is located in exon 4 (coding exon 2) of the POMC gene. This alteration results from a T to G substitution at nucleotide position 250, causing the tryptophan (W) at amino acid position 84 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.55
BayesDel_addAF
Pathogenic
0.29
D
BayesDel_noAF
Pathogenic
0.30
CADD
Pathogenic
28
DANN
Benign
0.96
DEOGEN2
Uncertain
0.56
D;D;D;D;T
Eigen
Uncertain
0.45
Eigen_PC
Uncertain
0.41
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Pathogenic
0.98
D;.;.;.;D
M_CAP
Uncertain
0.16
D
MetaRNN
Pathogenic
0.84
D;D;D;D;D
MetaSVM
Uncertain
0.20
D
MutationAssessor
Uncertain
2.7
M;M;M;M;.
PhyloP100
3.9
PrimateAI
Pathogenic
0.88
D
PROVEAN
Pathogenic
-8.4
D;D;D;D;D
REVEL
Pathogenic
0.79
Sift
Uncertain
0.0010
D;D;D;D;D
Sift4G
Uncertain
0.0020
D;D;D;D;.
Polyphen
0.98
D;D;D;D;.
Vest4
0.64
MutPred
0.50
Loss of stability (P = 0.0072);Loss of stability (P = 0.0072);Loss of stability (P = 0.0072);Loss of stability (P = 0.0072);Loss of stability (P = 0.0072);
MVP
0.97
MPC
1.3
ClinPred
0.80
D
GERP RS
4.0
Varity_R
0.83
gMVP
0.47
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs748145117; hg19: chr2-25384504; API